Literature DB >> 2794061

Sequence and exon-intron organization of the DNA encoding the alpha I domain of human spectrin. Application to the study of mutations causing hereditary elliptocytosis.

K E Sahr1, T Tobe, A Scarpa, K Laughinghouse, S L Marchesi, P Agre, A J Linnenbach, V T Marchesi, B G Forget.   

Abstract

We have determined the exon-intron organization and the nucleotide sequence of the exons and their flanking intronic DNA in cloned genomic DNA that encodes the first 526 amino acids of the alpha I domain of the human red cell spectrin polypeptide chain. From the gene sequence we designed oligonucleotide primers to use in the polymerase chain reaction technique to amplify the appropriate exons in DNA from individuals with three variants of hereditary elliptocytosis characterized by the presence of abnormal alpha I spectrin peptides, 46-50 and 65-68 kD in size, in partial tryptic digests of spectrin. The alpha I/68-kD abnormality resulted from a duplication of leucine codon 148 in exon 4: TTG-CTG to TTG-TTG-CTG. The alpha I/50a defect was associated in different individuals with two separate single base changes in exon 6: CTG to CCG (leucine to proline) encoding residue 254, and TCC to CCC (serine to proline) encoding residue 255. In another individual with the alpha I/50a polypeptide defect, the nucleotide sequence encoding amino acid residues 221 through 264 was normal. The alpha I/50b abnormality resulted from a single base change of CAG (glutamine) to CCG (proline) encoding residue 465 in exon 11 in two unrelated individuals. In a third individual with alpha I/50b-kD hereditary elliptocytosis, the entire exon encoding residues 445 through 490 was normal. The relationship of the alpha I domain polypeptide structure to these mutations and the organization of the gene is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794061      PMCID: PMC329784          DOI: 10.1172/JCI114291

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Spectrin Tunis (Sp alpha I/78), an elliptocytogenic variant, is due to the CGG----TGG codon change (Arg----Trp) at position 35 of the alpha I domain.

Authors:  L Morlé; F Morlé; A F Roux; J Godet; B G Forget; L Denoroy; M Garbarz; D Dhermy; R Kastally; J Delaunay
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

Review 3.  Hereditary elliptocytosis, spherocytosis and related disorders: consequences of a deficiency or a mutation of membrane skeletal proteins.

Authors:  J Palek
Journal:  Blood Rev       Date:  1987-09       Impact factor: 8.250

4.  Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus.

Authors:  U B Gyllensten; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Molecular cloning of the cDNA for human erythrocyte beta-spectrin.

Authors:  J C Winkelmann; T L Leto; P C Watkins; R Eddy; T B Shows; A J Linnenbach; K E Sahr; N Kathuria; V T Marchesi; B G Forget
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

6.  Frameshift mutations and the genetic code. This paper is dedicated to Professor Theodosius Dobzhansky on the occasion of his 66th birthday.

Authors:  G Streisinger; Y Okada; J Emrich; J Newton; A Tsugita; E Terzaghi; M Inouye
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1966

7.  Sp alpha I/78: a mutation of the alpha I spectrin domain in a white kindred with HE and HPP phenotypes.

Authors:  M C Lecomte; M Garbarz; B Grandchamp; C Féo; H Gautero; I Devaux; O Bournier; C Galand; L d'Auriol; F Galibert
Journal:  Blood       Date:  1989-08-15       Impact factor: 22.113

8.  Molecular basis of Sp alpha I/65 hereditary elliptocytosis in North Africa: insertion of a TTG triplet between codons 147 and 149 in the alpha-spectrin gene from five unrelated families.

Authors:  A F Roux; F Morlé; D Guetarni; P Colonna; K Sahr; B G Forget; J Delaunay; J Godet
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

9.  [Research on genetic abnormality in the hemolytic form of hereditary elliptocytosis with homozygosity for the spectrin alpha I/74 variant].

Authors:  M Garbarz; I Devaux; B Grandchamp; C Picat; D Dhermy; M C Lecomte; P Boivin; K E Sahr; B Forget
Journal:  C R Acad Sci III       Date:  1989

10.  Human beta-globin messenger RNA. III. Nucleotide sequences derived from complementary DNA.

Authors:  C A Marotta; J T Wilson; B G Forget; S M Weissman
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

View more
  19 in total

1.  Alpha I/65 hereditary elliptocytosis in southern Italy: evidence for an African origin.

Authors:  E M del Giudice; M T Ducluzeau; N Alloisio; R Wilmotte; J Delaunay; S Perrotta; S Cutillo; A Iolascon
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

2.  Evidence that expression of Sp alpha I/65 hereditary elliptocytosis is compounded by a genetic factor that is linked to the homologous alpha-spectrin allele.

Authors:  D Guetarni; A F Roux; N Alloisio; F Morlé; M T Ducluzeau; B G Forget; P Colonna; J Delaunay; J Godet
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

Review 3.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

4.  Sp alpha V/41: a common spectrin polymorphism at the alpha IV-alpha V domain junction. Relevance to the expression level of hereditary elliptocytosis due to alpha-spectrin variants located in trans.

Authors:  N Alloisio; L Morlé; J Maréchal; A F Roux; M T Ducluzeau; D Guetarni; B Pothier; F Baklouti; A Ghanem; R Kastally; J Delaunay
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

5.  Fast screening methods to detect mutations of spectrin in subjects with hereditary elliptocytosis.

Authors:  L Boulanger; M C LeCompte; D Dhermy; M Garbarz
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

6.  Two elliptocytogenic alpha I/74 variants of the spectrin alpha I domain. Spectrin Culoz (GGT----GTT; alpha I 40 Gly----Val) and spectrin Lyon (CTT----TTT; alpha I 43 Leu---Phe).

Authors:  L Morlé; A F Roux; N Alloisio; B Pothier; J Starck; L Denoroy; F Morlé; R C Rudigoz; B G Forget; J Delaunay
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

7.  Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis.

Authors:  T L Coetzer; K Sahr; J Prchal; H Blacklock; L Peterson; R Koler; J Doyle; J Manaster; J Palek
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

8.  An alpha-spectrin mutation responsible for hereditary elliptocytosis associated in cis with the alpha v/41 polymorphism.

Authors:  N Dalla Venezia; R Wilmotte; L Morlé; A Forissier; N Parquet; M Garbarz; T Rousset; D Dhermy; N Alloisio; J Delaunay
Journal:  Hum Genet       Date:  1993-02       Impact factor: 4.132

9.  Low expression allele alpha LELY of red cell spectrin is associated with mutations in exon 40 (alpha V/41 polymorphism) and intron 45 and with partial skipping of exon 46.

Authors:  R Wilmotte; J Maréchal; L Morlé; F Baklouti; N Philippe; R Kastally; L Kotula; J Delaunay; N Alloisio
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.

Authors:  P G Gallagher; W T Tse; T Coetzer; M C Lecomte; M Garbarz; H S Zarkowsky; A Baruchel; S K Ballas; D Dhermy; J Palek
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.